These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38373930)

  • 1. Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
    Yu XW; She PW; Chen FC; Chen YY; Zhou S; Wang XM; Lin XR; Liu QL; Huang ZJ; Qiu Y
    BMC Cancer; 2024 Feb; 24(1):230. PubMed ID: 38373930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer.
    Chen Y; Huang X; Chen L; Weng G; Huang Z; Zhang Y; Xiao T; Chen J; Zhu K; Xu Y
    Mol Biotechnol; 2023 Mar; 65(3):361-383. PubMed ID: 35780460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of ferroptosis and stemness based on single-cell and bulk RNA-sequencing data provide insights into the prognosis and treatment of esophageal carcinoma.
    Sui X; Wang W; Zhang D; Xu J; Li J; Jia Y; Qin Y
    Gene; 2024 Nov; 927():148701. PubMed ID: 38885819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and Immunotherapy.
    Zhou Y; Che Y; Fu Z; Zhang H; Wu H
    Front Public Health; 2022; 10():902378. PubMed ID: 35875026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment.
    Wang Z; Chen M; Qiu Y; Yang Y; Huang Y; Li X; Zhang W
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33543230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of pyroptosis-related genes are correlated with immune microenvironment and predict prognosis in ESCA.
    Shi Y; Yang Q; Tai G; Chen X
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10701-10713. PubMed ID: 37302999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the Hypoxia-immune interface in esophageal squamous carcinoma: a prognostic network model.
    Hu J; Liu Q; Feng B; Lu Y; Chen K
    Front Oncol; 2023; 13():1296814. PubMed ID: 38148838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of genome-wide copy number variation-driven subtypes for the treatment and prognostic prediction of esophageal carcinoma.
    Zhao C; Han H; Tian Y; Qu G; Xu Y; Wang Y; Shi L
    Heliyon; 2024 Oct; 10(19):e38011. PubMed ID: 39386821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridging Integrator 3 (BIN3) Downregulation Predicts a Poor Prognosis in Patients with Esophagus Carcinoma: A Study based on TCGA Data.
    Li D; Deng W; Huang G; Xiao X
    Comb Chem High Throughput Screen; 2023; 26(11):1974-1989. PubMed ID: 36475339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis.
    Cao X; Wu B; Guo S; Zhong W; Zhu S; Zhang Z; Gu L; Li H
    Pathol Oncol Res; 2023; 29():1610976. PubMed ID: 36969562
    [No Abstract]   [Full Text] [Related]  

  • 13. Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer.
    Hou J; Yang Y; Gao H; Ouyang T; Liu Q; Ding R; Kan H
    Medicine (Baltimore); 2022 Oct; 101(40):e30888. PubMed ID: 36221371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the molecular profiling and tumor immune microenvironment of three subtypes of esophageal cancer.
    Yu C; Xi Y; Zhang P; He N; Shen W
    J Gene Med; 2023 May; 25(5):e3482. PubMed ID: 36786041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer.
    Bi Y; Liu J; Qin S; Ji F; Zhou C; Yang H; Zhou S
    Front Immunol; 2024; 15():1295011. PubMed ID: 38562942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhein suppresses esophageal cancer development by regulating cell cycle through DNMT3B gene.
    Li C; Yu J; Feng Y; Sun X; Sun M; Ni W; Shao J; Wang B
    Med Oncol; 2024 May; 41(6):153. PubMed ID: 38743323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas.
    Ding H; Xu JC; Ding ZG; Wu LF; Liu YB; Zhang YF; Chen TY; Zhang YQ; Zhou PH
    Front Immunol; 2024; 15():1295305. PubMed ID: 38481990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. eIF6 is potential diagnostic and prognostic biomarker that associated with
    Gao Y; Yuan L; Zeng J; Li F; Li X; Tan F; Liu X; Wan H; Kui X; Liu X; Ke C; Pei Z
    J Transl Med; 2022 Jul; 20(1):303. PubMed ID: 35794622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
    Wu K; Zhang C; Zhang C; Dai D
    Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycerol kinase enzyme is a prognostic predictor in esophageal carcinoma and is associated with immune cell infiltration.
    Ying F; Chen X; Lv L
    Sci Rep; 2024 Feb; 14(1):3922. PubMed ID: 38365953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.